Basics |
Pulmonx Corporation
|
IPO Date: |
October 1, 2020 |
Sector: |
Healthcare |
Industry: |
Medical Devices |
Market Cap: |
$124.19M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.58 | 2.95%
|
Avg Daily Range (30 D): |
$0.18 | 4.34%
|
Avg Daily Range (90 D): |
$0.24 | 3.96%
|
Institutional Daily Volume |
Avg Daily Volume: |
.31M |
Avg Daily Volume (30 D): |
.34M |
Avg Daily Volume (90 D): |
.31M |
Trade Size |
Avg Trade Size (Sh.): |
73 |
Avg Trade Size (Sh.) (30 D): |
74 |
Avg Trade Size (Sh.) (90 D): |
72 |
Institutional Trades |
Total Inst.Trades: |
992 |
Avg Inst. Trade: |
$1.67M |
Avg Inst. Trade (30 D): |
$.65M |
Avg Inst. Trade (90 D): |
$.74M |
Avg Inst. Trade Volume: |
.08M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.63M |
Avg Closing Trade (30 D): |
$.65M |
Avg Closing Trade (90 D): |
$.56M |
Avg Closing Volume: |
66.17K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-.36
|
|
$-1.44
|
Diluted EPS
|
$-.36
|
|
$-1.44
|
Revenue
|
$ 22.54M
|
$
|
$ 83.79M
|
Gross Profit
|
$ 16.34M
|
$
|
$ 62M
|
Net Income / Loss
|
$ -14.45M
|
$
|
$ -56.39M
|
Operating Income / Loss
|
$ -14.56M
|
$
|
$ -57.7M
|
Cost of Revenue
|
$ 6.2M
|
$
|
$ 21.79M
|
Net Cash Flow
|
$ 3.65M
|
$
|
$ -12.62M
|
PE Ratio
|
|
|
|
|